WallStreetZenWallStreetZen

NASDAQ: FGEN
Fibrogen Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for FGEN

Based on 1 analyst offering 12 month price targets for Fibrogen Inc

Min Forecast
$10.00+2,806.98%
Avg Forecast
$10.00+2,806.98%
Max Forecast
$10.00+2,806.98%

Should I buy or sell FGEN stock?

Based on 1 analyst offering ratings for Fibrogen Inc.

Buy
Strong Buy
0 analysts 0%
Buy
1 analysts 100%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their FGEN stock forecasts and price targets.

FGEN stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-05-13

1 of 1

Forecast return on equity

Is FGEN forecast to generate an efficient return?

Insufficient data to display

Forecast return on assets

Is FGEN forecast to generate an efficient return on assets?

Company
-38.53%
Industry
39.01%
FGEN is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

FGEN earnings per share forecast

What is FGEN's earnings per share in the next 3 years based on estimates from 2 analysts?

Avg 1 year Forecast
-$0.70
Avg 2 year Forecast
-$0.73
Avg 3 year Forecast
-$0.64

FGEN revenue forecast

What is FGEN's revenue in the next 3 years based on estimates from 2 analysts?

Avg 1 year Forecast
$9.9M
Avg 2 year Forecast
$9.6M
Avg 3 year Forecast
$9.9M

FGEN vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
FGEN$0.34$10.00+2,806.98%Buy
LVTX$1.32$3.17+139.92%Hold
FBLG$0.91$13.33+1,360.35%Strong Buy
ESLA$0.98$16.00+1,532.65%Strong Buy
COEP$9.66N/AN/A
View Top Biotech Stocks

Fibrogen Stock Forecast FAQ

Is Fibrogen Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: FGEN) stock is to Buy FGEN stock.

Out of 1 analyst, 0 (0%) are recommending FGEN as a Strong Buy, 1 (100%) are recommending FGEN as a Buy, 0 (0%) are recommending FGEN as a Hold, 0 (0%) are recommending FGEN as a Sell, and 0 (0%) are recommending FGEN as a Strong Sell.

If you're new to stock investing, here's how to buy Fibrogen stock.

What is FGEN's earnings growth forecast for 2025-2027?

(NASDAQ: FGEN) Fibrogen's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 10.63%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 15.45%.

Fibrogen's earnings in 2025 is -$10,007,000.On average, 2 Wall Street analysts forecast FGEN's earnings for 2025 to be -$70,225,559, with the lowest FGEN earnings forecast at -$105,085,729, and the highest FGEN earnings forecast at -$35,365,390. On average, 2 Wall Street analysts forecast FGEN's earnings for 2026 to be -$73,256,878, with the lowest FGEN earnings forecast at -$87,908,254, and the highest FGEN earnings forecast at -$58,605,503.

In 2027, FGEN is forecast to generate -$64,668,141 in earnings, with the lowest earnings forecast at -$73,762,098 and the highest earnings forecast at -$55,574,184.

What is FGEN's revenue growth forecast for 2025-2027?

(NASDAQ: FGEN) Fibrogen's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 57.7%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.75%.

Fibrogen's revenue in 2025 is -$23,543,000.On average, 2 Wall Street analysts forecast FGEN's revenue for 2025 to be $995,283,105, with the lowest FGEN revenue forecast at $707,307,790, and the highest FGEN revenue forecast at $1,283,258,419. On average, 2 Wall Street analysts forecast FGEN's revenue for 2026 to be $970,022,112, with the lowest FGEN revenue forecast at $606,263,820, and the highest FGEN revenue forecast at $1,333,780,404.

In 2027, FGEN is forecast to generate $995,283,105 in revenue, with the lowest revenue forecast at $606,263,820 and the highest revenue forecast at $1,384,302,389.

What is FGEN's forecast return on assets (ROA) for 2025-2028?

(NASDAQ: FGEN) forecast ROA is -38.53%, which is lower than the forecast US Biotechnology industry average of 39.01%.

What is FGEN's Price Target?

According to 1 Wall Street analyst that have issued a 1 year FGEN price target, the average FGEN price target is $10.00, with the highest FGEN stock price forecast at $10.00 and the lowest FGEN stock price forecast at $10.00.

The Wall Street analyst predicted that Fibrogen's share price could reach $10.00 by May 13, 2026. The average Fibrogen stock price prediction forecasts a potential upside of 2,806.98% from the current FGEN share price of $0.34.

What is FGEN's Earnings Per Share (EPS) forecast for 2025-2027?

(NASDAQ: FGEN) Fibrogen's current Earnings Per Share (EPS) is -$0.10. On average, analysts forecast that FGEN's EPS will be -$0.70 for 2025, with the lowest EPS forecast at -$1.04, and the highest EPS forecast at -$0.35. On average, analysts forecast that FGEN's EPS will be -$0.73 for 2026, with the lowest EPS forecast at -$0.87, and the highest EPS forecast at -$0.58. In 2027, FGEN's EPS is forecast to hit -$0.64 (min: -$0.73, max: -$0.55).

What is FGEN's forecast return on equity (ROE) for 2025-2028?

(NASDAQ: FGEN) forecast ROE is N/A, which is considered weak.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.